📣 VC round data is live. Check it out!
- Public Comps
- CVS Group
CVS Group Valuation Multiples
Discover revenue and EBITDA valuation multiples for CVS Group and similar public comparables like Oil-Dri Corp of America, Pet Valu, Vetoquinol, XPS Pensions Group and more.
CVS Group Overview
About CVS Group
CVS Group PLC is a veterinary service provider in the United Kingdom. The group operates through three business divisions: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. The veterinary practice segment generates the majority of the revenues. The company facilitates its veterinary services through its diagnostics, laboratory reports, and pet cremation services. It also offers retail pharmacy through Animed Direct. Geographically, it generates the majority of its revenue from the United Kingdom and also operates in Australia.
Founded
2007
HQ

Employees
8.9K
Website
Sectors
Financials (LTM)
EV
$1B
Valuation Multiples
Start free trialCVS Group Financials
CVS Group reported last 12-month revenue of $958M and EBITDA of $190M.
In the same LTM period, CVS Group generated $408M in gross profit, $190M in EBITDA, and $83M in net income.
Revenue (LTM)
CVS Group P&L
In the most recent fiscal year, CVS Group reported revenue of $914M and EBITDA of $181M.
CVS Group is profitable as of last fiscal year, with gross margin of 42%, EBITDA margin of 20%, and net margin of 8%.
Financial data powered by Morningstar, Inc.
CVS Group Stock Performance
CVS Group has current market cap of $1B, and enterprise value of $1B.
Market Cap Evolution
CVS Group's stock price is $15.89.
CVS Group share price increased by 1.8% in the last 30 days, and decreased by 4.1% in the last year.
CVS Group has an EPS (earnings per share) of $1.10.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $1B | -0.2% | 1.8% | -11.8% | -4.1% | $1.10 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCVS Group Valuation Multiples
CVS Group trades at 1.5x EV/Revenue multiple, and 7.7x EV/EBITDA.
EV / Revenue (LTM)
CVS Group Financial Valuation Multiples
As of May 5, 2026, CVS Group has market cap of $1B and EV of $1B.
CVS Group has a P/E ratio of 13.4x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified CVS Group Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


CVS Group Margins & Growth Rates
CVS Group grew revenue by 6% and EBITDA by 6% in the last fiscal year.
In the most recent fiscal year, CVS Group reported gross margin of 42%, EBITDA margin of 20%, and net margin of 8%.
CVS Group Margins
CVS Group Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
CVS Group Operational KPIs
CVS Group's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.
CVS Group's Rule of 40 is 25% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
CVS Group's Rule of X is 33% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
CVS Group Competitors
CVS Group competitors include Oil-Dri Corp of America, Pet Valu, Vetoquinol, XPS Pensions Group, Petco, CEWE Group, Carriage Services, i-Tail, Musti Group and Spectrum Brands.
Most CVS Group public comparables operate across Pet Care and Personal Services.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 2.2x | — | 11.6x | — | |||
| 1.9x | 1.9x | 8.5x | 8.4x | |||
| 1.3x | 1.3x | 5.7x | 6.1x | |||
| 3.0x | 2.7x | 10.2x | 9.4x | |||
| 0.6x | 0.6x | 10.5x | 8.3x | |||
| 0.7x | 0.7x | 4.4x | 4.5x | |||
| 3.1x | 3.1x | 10.5x | 9.8x | |||
| 2.0x | 1.9x | 9.7x | 9.5x | |||
This data is available for Pro users. Sign up to see all CVS Group competitors and their valuation data. Start Free Trial | ||||||
CVS Group M&A Activity
CVS Group has acquired 78 companies to date.
Last acquisition by CVS Group was on August 23rd 2021. CVS Group acquired The Vet for undisclosed valuation.
Latest Acquisitions by CVS Group
| Description | The Vet is a UK veterinary chain with 50 clinics delivering affordable primary care services like vaccinations, check-ups, and treatments for cats, dogs, and small pets. Headquartered in Manchester, it emphasizes transparent pricing and nurse consultations to reduce costs for pet owners. | Market Hall Vets is a UK veterinary practice in Norfolk providing farm animal care and 24-hour emergency services. Its team of experienced vets handles cattle, sheep, and equine cases with training in advanced diagnostics and surgery. The practice serves local farmers through on-site visits and consultations on herd health management. | Gilabbey Veterinary Hospital is a Cork-based small animal practice founded in 1957 by Liam Guerin. The hospital provides comprehensive veterinary services including surgery, diagnostics, and emergency care, with staff holding national and international reputations in continuing education for the veterinary profession. | Troytown Greyabbey Equine Veterinary Services is a Northern Ireland-based equine hospital specializing in diagnostics and treatment of injuries and diseases in performance horses. Located in Greyabbey, County Down, the facility offers advanced imaging, surgery, and rehabilitation services for racehorses and sport horses from the UK and Ireland. Established through a 2012 merger, it employs specialists in orthopedics and internal medicine, treating clients from major stables including those competing at Cheltenham Festival and Dublin Horse Show. | |
| HQ Country | |||||
| HQ City | Bristol | Saint Clears | Cork | Kildare | |
| Deal Date | 23 Aug 2021 | 23 Feb 2021 | 23 Aug 2018 | 5 Aug 2018 | |
| Valuation | undisclosed | undisclosed | undisclosed | undisclosed | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all CVS Group acquisitions and their M&A valuation multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout CVS Group
| When was CVS Group founded? | CVS Group was founded in 2007. |
| Where is CVS Group headquartered? | CVS Group is headquartered in United Kingdom. |
| How many employees does CVS Group have? | As of today, CVS Group has over 8K employees. |
| Who is the CEO of CVS Group? | CVS Group's CEO is Richard William Mark Fairman. |
| Is CVS Group publicly listed? | Yes, CVS Group is a public company listed on London Stock Exchange. |
| What is the stock symbol of CVS Group? | CVS Group trades under CVSG ticker. |
| When did CVS Group go public? | CVS Group went public in 2007. |
| Who are competitors of CVS Group? | CVS Group main competitors include Oil-Dri Corp of America, Pet Valu, Vetoquinol, XPS Pensions Group, Petco, CEWE Group, Carriage Services, i-Tail, Musti Group, Spectrum Brands. |
| What is the current market cap of CVS Group? | CVS Group's current market cap is $1B. |
| What is the current revenue of CVS Group? | CVS Group's last 12 months revenue is $958M. |
| What is the current revenue growth of CVS Group? | CVS Group revenue growth (NTM/LTM) is 5%. |
| What is the current EV/Revenue multiple of CVS Group? | Current revenue multiple of CVS Group is 1.5x. |
| Is CVS Group profitable? | Yes, CVS Group is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of CVS Group? | CVS Group's last 12 months EBITDA is $190M. |
| What is CVS Group's EBITDA margin? | CVS Group's last 12 months EBITDA margin is 20%. |
| What is the current EV/EBITDA multiple of CVS Group? | Current EBITDA multiple of CVS Group is 7.7x. |
| What is the current FCF of CVS Group? | CVS Group's last 12 months FCF is $89M. |
| What is CVS Group's FCF margin? | CVS Group's last 12 months FCF margin is 9%. |
| What is the current EV/FCF multiple of CVS Group? | Current FCF multiple of CVS Group is 16.4x. |
| How many companies CVS Group has acquired to date? | As of May 2026, CVS Group has acquired 78 companies. |
| What was the largest acquisition by CVS Group? | $16M acquisition of Aire Veterinary Centre on 28th September 2017 was the largest M&A CVS Group has done to date. |
| What companies CVS Group acquired? | CVS Group acquired Aire Veterinary Centre, O'Reilly & Fee Veterinary Surgery, Your Vets, Albavet, Alnorthumbria Veterinary Group, Highcroft Pet Care, West Mount Vets, Haven Veterinary Surgeons, B&W Equine Vets, Dierenarts Arnhem, and 68 other companies. |
| In how many companies CVS Group has invested to date? | CVS Group hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to CVS Group
Lists including CVS Group
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

